Clinical trials: open to volunteers, sponsored by University Health Network, Toronto
Ataxia, Gait
Cerebellar Deep Brain Stimulation for the Treatment of Ataxia
Abnormal gait is often associated with immobility and falls, which in turn lead to loss of functional independence and death. While gait disorders may arise from many different etiologies, dysfunction of the cerebellum (a part of…
- Trial name
- DBS-Ataxia (NCT07427563)
- Testing
- Deep Brain Stimulation
- Where
- Canada
- Volunteers
- 12 people
- Sponsor
- University Health Network, Toronto
Long COVID, Post Acute Sequelae of COVID-19
Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition
The RECLAIM study platform will be used to explore whether the use of Hyperbaric Oxygen therapy (HBOT) improves the symptoms of post covid cognitive dysfunction. Hyperbaric oxygen therapy is a well-established medical treatment.
- Conditions
- Long COVID, Post Acute Sequelae of COVID-19, Post-COVID-19 Condition
- Trial name
- RECLAIM-HBOT (NCT06452095)
- Testing
- Hyperbaric Oxygen therapy
- Where
- Canada
- Volunteers
- 120 people
- Sponsor
- University Health Network, Toronto
CMV, Lung Transplant Recipient
Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients
The primary objective of the CLEAR-CMV trial is to evaluate the efficacy of letermovir therapy plus standard of care (SOC) antiviral compared to SOC plus placebo in achieving clearance of CMV viremia by week 3 in lung transplant…
- Trial name
- CLEAR-CMV (NCT07235683)
- Testing
- Letermovir, Valganciclovir/Ganciclovir
- Where
- Canada
- Volunteers
- 40 people
- Sponsor
- University Health Network, Toronto
Glaucoma, Biofeedback Training
Efficacy of Biofeedback Training for Glaucoma
This randomized controlled clinical trial evaluates the efficacy of visual biofeedback training on visual function and quality of life in individuals with glaucoma.
- Trial name
- NCT07409077
- Testing
- Biofeedback Training
- Where
- Canada
- Volunteers
- 70 people
- Sponsor
- University Health Network, Toronto
Advanced Prostate Cancer
Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer
This study will use Prostate Specific Membrane Antigen (PSMA) and (18)F-Fluorodeoxyglucose Positron Emission Tomography (FDG PET) imaging in patients with advanced prostate cancer to learn about tumor biology across disease…
- Trial name
- NCT06335914
- Testing
- Ga 68 PSMA-11 PET, 18F-DCFPyL PET, FDG PET
- Where
- Canada
- Volunteers
- 30 people
- Sponsor
- University Health Network, Toronto
Chronic Iron Deficiency Anaemia, Cardiac Surgery
Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery
POAM is a multicenter, randomized, controlled, internal pilot trial, using a conventional, parallel group, two-armed design at 3 cardiac surgery centres in Canada.
- Trial name
- POAM (NCT06287619)
- Testing
- Monoferric Injectable Product, 0.9% sodium chloride solution
- Where
- 3 sites in Canada
- Volunteers
- 60 people
- Sponsor
- University Health Network, Toronto
Cognitive Impairment
Radialis PET Imager for the Assessment of Neuritic Amyloid Plaque Burden
The standard or usual workup for cognitive impairment, including Alzheimer's Disease, may include brain amyloid PET with PET/CT or PET/MR imaging.
- Trial name
- Amyloid RPI (NCT06757569)
- Testing
- PET
- Where
- Canada
- Volunteers
- 160 people
- Sponsor
- University Health Network, Toronto
Ovarian Cancer (OvCa), Recurrent Ovarian Cancer
Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian Cancer
The goal of this clinical trial is to investigate if CALM-TF (Trauma-Focused Managing Cancer and Living Meaningfully) is effective in treating traumatic stress symptoms in women with advanced ovarian cancer.
- Trial name
- CALM-TF (NCT07286162)
- Testing
- Trauma-Focused Managing Cancer and Living Meaningfully
- Where
- Canada
- Volunteers
- 300 people
- Sponsor
- University Health Network, Toronto
Brain Metastases, Brain Metastasis
Feasibility of a Cognitive Stepped Care Program for Adults With Brain Metastases
Background: Cognitive symptoms are common and often severe in patients with brain metastases, significantly impacting their quality of life and ability to manage cancer care.
- Trial name
- NCT07355348
- Testing
- Cognitive Stepped Care Program (CSCP)
- Where
- Canada
- Volunteers
- 140 people
- Sponsor
- University Health Network, Toronto
Neck Pain, Zygapophyseal Joint Arthritis
End-on Versus Parallel Radiofrequency Lesioning for Neurotomy of the Cervical Medial Branch Nerves
Aim of the EndPaRL study is to compare the efficacy and effectiveness of the two techniques utilizing sharp straight conventional radiofrequency needle with a trident needle for radiofrequency neurotomy of Cervical Medial Branch…
- Trial name
- EndPaRL (NCT05818774)
- Testing
- Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with parallel lesioning, Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with end-on lesioning with multitined trident cannulae
- Where
- 3 sites in Canada, Spain
- Volunteers
- 72 people
- Sponsor
- University Health Network, Toronto
Opioid Use
Opioid Use Post-Discharge After Ambulatory Distal Arm Surgery
The aim of this study is to determine if a standardized evidence-based opioid prescription following elective hand and forearm surgery at Toronto Western Hospital (TWH) will decrease the number of unused opioid pills consumed by…
- Trial name
- NCT04044820
- Testing
- Standardized Prescription
- Where
- Canada
- Volunteers
- 292 people
- Sponsor
- University Health Network, Toronto
Spontaneous Intracranial Hypotension
Greater Occipital Nerve Block for Spontaneous Intracranial Hypotension
Spontaneous Intracranial Hypotension (SIH) is a debilitating neurological disorder caused by a cerebrospinal fluid leak (CSF), with an estimated incidence of 5 per 100,000 persons per year, of which mostly women between the ages…
- Trial name
- NCT06374524
- Testing
- greater occipital nerve block
- Where
- Canada
- Volunteers
- 34 people
- Sponsor
- University Health Network, Toronto
Neuropathic Pain, Chronic Pain
Mechanisms and Outcome-Prognostication for Paresthesia-based and -Free Spinal Cord Stimulation
Spinal cord stimulation (SCS) relies on stimulation of pain-relieving pathways in the spinal cord to treat chronic neuropathic pain.
- Trial name
- MOPPStim (NCT03852381)
- Testing
- Spinal Cord Stimulation
- Where
- Canada
- Volunteers
- 90 people
- Sponsor
- University Health Network, Toronto
Gynecological Cancers
Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers
This is an open-label, first-in-human, dose escalation study evaluating investigational drug PORPHYSOSMES (PS, pegylated porphyrin-lipid conjugate-containing nanoparticle suspension) and 64Cu-PORPHYSOMES (64Cu-PS, pegylated…
- Trial name
- NCT06977126
- Testing
- PORPHYSOMES, 64Cu-PORPHYSOMES
- Where
- Canada
- Volunteers
- 24 people
- Sponsor
- University Health Network, Toronto
Respiratory Insufficiency, Neuromuscular Blockade
Partial Neuromuscular Blockade in Acute Hypoxemic Respiratory Failure
PNEUMA is a preliminary safety and feasibility trial of a novel approach to the titration of neuromuscular blockade (NMB) to safe spontaneous breathing in patients with moderate to severe acute hypoxemic respiratory failure…
- Conditions
- Respiratory Insufficiency, Neuromuscular Blockade, Mechanical Ventilation
- Trial name
- PNEUMA (NCT04524585)
- Testing
- Cisatracurium
- Where
- Canada
- Volunteers
- 23 people
- Sponsor
- University Health Network, Toronto
Cervical Spinal Cord Injury
Feasibility and Safety of a Combined Augmented Reality and Functional Electrical Stimulation System
Cervical spinal cord injury (cSCI) can result in substantial loss of upper-limb function, with associated socio-economic impact on affected individuals and the healthcare system.
- Trial name
- NCT07299734
- Testing
- AR + FES
- Where
- Canada
- Volunteers
- 7 people
- Sponsor
- University Health Network, Toronto
Lymphadenopathy Retroperitoneal, Stage II Testicular Seminoma
R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
This study will investigate the safety and efficacy of using robotic retroperitoneal lymph node dissection (R-RPLND), a minimally invasive surgical approach, as the first-line of treatment for stage IIA/B (or equivalent) seminoma…
- Trial name
- NCT05345158
- Testing
- Robotic Retroperitoneal Lymph Node Dissection (RPLND)
- Where
- Canada
- Volunteers
- 25 people
- Sponsor
- University Health Network, Toronto
Non Small Cell Lung Cancer, Complete Surgical Resection
Using ctDNA to Determine Therapies for Lung Cancer
This is a study to look at whether the presence of circulating tumour DNA (ctDNA) in the blood can help to predict whether giving adjuvant treatment after surgery can decrease the chance of the cancer coming back in people with…
- Conditions
- Non Small Cell Lung Cancer, Complete Surgical Resection, Circulating Tumor DNA
- Trial name
- ctDNA Lung RCT (NCT04966663)
- Testing
- Nivolumab, Pemetrexed, Gemcitabine
- Where
- Canada
- Volunteers
- 66 people
- Sponsor
- University Health Network, Toronto
Trauma and Stressor Related Disorders, Pediatric Cancer
Emotion and Symptom-Focused Engagement (EASE) for Caregivers
The goal of this Phase III randomized controlled trial is to evaluate the effectiveness of a novel psychotherapeutic intervention called Emotion and Symptom-focused Engagement (EASE) in parents caring for a child or adolescent…
- Conditions
- Trauma and Stressor Related Disorders, Pediatric Cancer, Caregiver Burden
- Trial name
- EASE (NCT06367556)
- Testing
- Emotion and Symptom-Focused Engagement (EASE)
- Where
- 2 sites in Canada
- Volunteers
- 306 people, healthy volunteers welcome
- Sponsor
- University Health Network, Toronto
Advanced Cancer, Rare Diseases
Umbrella Study for Single Patient Treatments in Oncology
The purpose of this study is to collect data for assessing the improvement of the overall response rate for the overall cohorts and the proportion of patients accessing precision targeted therapy.
- Trial name
- UNIQUE (NCT06285500)
- Testing
- Patient-specific treatments
- Where
- Canada
- Volunteers
- 400 people
- Sponsor
- University Health Network, Toronto